1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 15 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Young-onset colorectal cancer in New South Wales: a population-based studyBoyce, S.; Nassar, N.; Lee, C.; Suen, M.; Zahrani, S.; Gladman, M.
2012The urgency of saving lives through bowel cancer screeningOlver, I.N.; Young, G.P.
2012Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the colorectal cancer family registryLevine, A.; Win, A.; Buchanan, D.; Jenkins, M.; Baron, J.; Young, J.; Long, T.; Weisenberger, D.; Laird, P.; McCall, R.; Duggan, D.; Haile, R.
2015Blood-based protein biomarker panel for the detection of colorectal cancerFung, K.; Tabor, B.; Buckley, M.; Priebe, I.; Purins, L.; Pompeia, C.; Brierley, G.; Lockett, T.; Gibbs, P.; Tie, J.; McMurrick, P.; Moore, J.; Ruszkiewicz, A.; Nice, E.; Adams, T.; Burgess, A.; Cosgrove, L.; Hoheisel, J.
2013PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerDay, F.; Jorissen, R.; Lipton, L.; Mouradov, D.; Sakthianandeswaren, A.; Christie, M.; Li, S.; Tsui, C.; Tie, J.; Desai, J.; Xu, Z.; Molloy, P.; Whitehall, V.; Leggett, B.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; et al.
2015Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerPrice, T.; Bruhn, M.; Lee, C.; Hardingham, J.; Townsend, A.; Mann, K.; Simes, J.; Weickhardt, A.; Wrin, J.; Wilson, K.; Gebski, V.; Van Hazel, G.; Robinson, B.; Cunningham, D.; Tebbutt, N.
2011Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancerDeenen, M.; Tol, J.; Burylo, A.; Doodeman, V.; de Boer, A.; Vincent, A.; Guchelaar, H.; Smits, P.; Beijnen, J.; Punt, C.; Schellens, J.; Cats, A.
2013Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapyPadman, S.; Padbury, R.; Beeke, C.; Karapetis, C.; Bishnoi, S.; Townsend, A.; Maddern, G.; Price, T.
2012Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerKhattak, M.; Townsend, A.; Beeke, C.; Karapetis, C.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
2013Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17Vickers, M.; Karapetis, C.; Tu, D.; O'Callaghan, C.; Price, T.; Tebbutt, N.; van Hazel, G.; Shapiro, J.; Pavlakis, N.; Gibbs, P.; Blondal, J.; Lee, U.; Meharchand, J.; Burkes, R.; Rubin, S.; Simes, J.; Zalcberg, J.; Moore, M.; Zhu, L.; Jonker, D.

Discover